BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
221 hedge funds and large institutions have $4.03B invested in Blueprint Medicines in 2023 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 73 increasing their positions, 77 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.28% more ownership
Funds ownership: 105.3% → 105.58% (+0.28%)
5% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 77
53% less call options, than puts
Call options by funds: $17.7M | Put options by funds: $37.4M
Holders
221
Holding in Top 10
4
Calls
$17.7M
Puts
$37.4M
Top Buyers
| 1 | +$114M | |
| 2 | +$42.7M | |
| 3 | +$37.4M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$31.6M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$26.2M |
Top Sellers
| 1 | -$134M | |
| 2 | -$20.1M | |
| 3 | -$19.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$15.9M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$15M |